In the dose-escalation and dose-expansion stages of the trial assesing TH-302 and low-dose dexamethasone without bortezomib, patients were heavily-pretreated, and objective responses were observed in 5/16 patients treated
The once-daily, single-entity pain medication was formulated to include abuse-deterrent properties designed to make the product more difficult to manipulate for misuse or abuse by various routes of
As part of the deal, Rohto will assess stem cell-derived human cells owned and provided by ISCO in a number of pre-clinical animal models. The company said that
Bendamustine hydrochloride is a ready-to-dilute concentrate solution for injection that will be administered by infusion over 10 minutes after dilution in 50mL of sodium chloride (saline) or a
The company intends to initiate shipments of the product prior to the upcoming cough/cold/flu season. Advil Congestion Relief Tablets, 200mg/10mg, (ibuprofen & phenylephrine hydrochloride tablets, 200mg/10mg) is indicated
The FDA acceptance follows the acceptance of the marketing authorization dossier for Toujeo by the European Medicines Agency (EMA) for EU countries in May 2014. The new drug
GKAs have the potential to differentiate from other anti-diabetic agents by exerting two potentially beneficial actions: promoting insulin secretion and decreasing glucose production by the liver. As a
The agreement is expected to allow ORGS to advance its manufacturing (GMP) process from lab scale to clinical scale as it prepares for Phase I and Phase II
Both, PSP and CBD represent diseases of the central nervous system and are collectively called as tauopathies, and for which no FDA approved therapies exist. The Phase I
Andexanet alfa is Portola’s investigational Factor Xa inhibitor antidote and edoxaban is Daiichi Sankyo’s Factor Xa inhibitor. The two firms have signed original collaboration agreement in June 2013
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.